ADAR1 Capital Management, LLC
InMed Pharmaceuticals Inc. · 10% Owner
ADAR1 Capital Management, LLC is listed in filings as 10% Owner at InMed Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including purchase activity and sale activity. Recent filings connect the profile to InMed Pharmaceuticals Inc. (INM), Rallybio Corporation (RLYB), Keros Therapeutics, Inc. (KROS), and Pieris Pharmaceuticals, Inc. (PIRS). The current snapshot covers public activity from Aug 12, 2024 to May 21, 2026. Reported amounts are shown as $312.1K to $2.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $312k200k shares | BuyMay 19, 2026 | $1.56 | $1.51 | |
| $300k200k shares | BuyMay 19, 2026 | $1.50 | $1.51 | |
| $2.8k200 shares | BuyMay 19, 2026 | $13.80 | $16.42 | |
| $140k10k shares | BuyMay 19, 2026 | $13.98 | $16.42 | |
| $110k68.6k shares | BuyMay 19, 2026 | $1.60 | $1.51 |